Melatonin action in tumor skeletal muscle cells: An ultrastructural study

Acta Histochemica

Volumn 118, Issue 3, 2016, Pages 278-285

  Burattini, S ^a   Battistelli, M ^a   Codenotti, S ^b   Falcieri, E ^a   Fanzani, A ^b   Salucci, S ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Apoptosis; Melatonin; Rhabdomyosarcoma

Indexed keywords

ALCOHOL; DIMETHYL SULFOXIDE; MELATONIN; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DISSOLUTION; HORMONE ACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; OXIDATIVE STRESS; RHABDOMYOSARCOMA CELL LINE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; DRUG SCREENING; IC50; MUSCLE NEOPLASMS; PATHOLOGY; RHABDOMYOSARCOMA; SKELETAL MUSCLE CELL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; MELATONIN; MUSCLE FIBERS, SKELETAL; MUSCLE NEOPLASMS; OXIDATIVE STRESS; RHABDOMYOSARCOMA;

EID: 84959461697     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2016.02.004     Document Type: Article

References (41)

1. Batista A.P., da Silva T.G., Teixeira A.A., de Medeiros P.L., Teixeira V.W., Alves L.C., Dos Santos F.A., Silva E.C. Ultrastructural aspects of melatonin cytotoxicity on Caco-2 cells in vitro. Micron 2014, 59:17-23.
2. Bejarano I., Redondo P.C., Espino J., Rosado J.A., Paredes S.D., Barriga C., Reiter R.J., Pariente J.A., Rodríguez A.B. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J. Pineal Res. 2009, 46:392-400.
3. Bizzarri M., Proietti S., Cucina A., Reiter R.J. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert Opin. Ther. Targets 2013, 17:1483-1496.
4. Bukowska A. Anticarcinogenic role of melatonin-potential mechanisms. Med. Pr. 2011, 62:425-434.
5. Büyükavci M., Ozdemir O., Buck S., Stout M., Ravindranath Y., Savaşan S. Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect. Fundam. Clin. Pharmacol. 2006, 20:73-79.
6. Codenotti S., Battistelli M., Burattini S., Salucci S., Falcieri E., Rezzani R., Faggi F., Colombi M., Monti E., Fanzani A. Melatonin decreases cell proliferation: impairs myogenic differentiation and triggers apoptotic cell death in rhabdomyosarcoma cell lines. Oncol. Rep. 2015, 34:279-287.
7. Chuffa L.G., Alves M.D., Martinez M., Camargo I., Pinheiro P., Domeniconi R., Lupi Júnior L.A., Martinez F. Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma. Endocr. Relat. Cancer 2015, pii: ERC-15-0463.
8. Dantonello T.M., Stark M., Timmermann B., Fuchs J., Selle B., Linderkamp C., Handgretinger R., Hagen R., Feuchtgruber S., Kube S., Kosztyla D., Kazanowska B., Ladenstein R., Niggli F., Ljungman G., Bielack S.S., Klingebiel T., Koscielniak E. Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma. Pediatr. Blood Cancer 2015, 62:16-23.
9. Faye M.D., Beug S.T., Graber T.E., Earl N., Xiang X., Wild B., Langlois S., Michaud J., Cowan K.N., Korneluk R.G., Holcik M. IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1. Oncogene 2015, 34:1532-1541.
10. Fulda S. Molecular targeted therapies for rhabdomyosarcoma: focus on hedgehog and apoptosis signaling. Klin. Padiatr. 2013, 225:115-119.
11. Ganie S.A., Dar T., Bhat A., Dar K., Anees S., Masood A., Zargar M.A. Melatonin: a potential antioxidant therapeutic agent for mitochondrial dysfunctions and related disorders. Rejuvenation Res. 2015, 18(June).
12. Gong L.H., Ren D.H., Xiong M., Lu Z.Q., Wang X.M. Melatonin in in vitro apoptosis of H22 hepatocarcinoma cells. Zhonghua Zhong Liu Za Zhi 2003, 25:550-554.
13. Hong Y., Won J., Lee Y., Lee S., Park K., Chang K.T., Hong Y. Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells. J. Pineal Res. 2014, 56:264-274.
14. Hrushesky W.J., Grutsch J., Wood P., Yang X., Oh E.Y., Ansell C., Kidder S., Ferrans C., Quiton D.F., Reynolds J., Du-Quiton J., Levin R., Lis C., Braun D. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr. Cancer Ther. 2009, 8:387-397.
15. Jardim-Perassi B.V., Arbab A.S., Ferreira L.C., Borin T.F., Varma N., Iskander A.S., Shankar A., Ali de Campos M.M., Zuccari D.A. Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer. PLoS One 2014, 9:e85311.
16. Jothi M., Mal M., Keller C., Mal A.K. Small molecule inhibition of PAX3-FOXO1 through AKT activation suppresses malignant phenotypes of alveolar rhabdomyosarcoma. Mol. Cancer Ther. 2013, 12:2663-2674.
17. Keller C., Arenkiel B.R., Coffin C.M., El-Bardeesy N., DePinho R.A., Capecchi M.R. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 2004, 18:2614-2626.
18. Keller C., Capecchi M.R. New genetic tactics to model alveolar rhabdomyosarcoma in the mouse. Cancer Res. 2005, 65:7530-7532.
19. Kubatka P., Bojková B., ciková-Kalická K M., Mníchová-Chamilová M., Adámeková E., Ahlers I., Ahlersová E., Cermáková M. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a) anthracene respectively, in female Sprague-Dawley rats. Folia Biol. (Praha) 2001, 47:5-10.
20. Lee C.O. Complementary and alternative medicines patients are talking about: melatonin. Clin. J. Oncol. Nurs. 2006, 10:105-107.
21. Leon-Blanco M.M., Guerrero J.M., Reiter R.J., Calvo J.R., Pozo D. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J. Pineal Res. 2003, 35:204-211.
22. Li S.Q., Cheuk A.T., Shern J.F., Song Y.K., Hurd L., Liao H., Wei J.S., Khan J. Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534). PLoS One 2013, 8:e76551.
23. Mao L., Yuan L., Slakey L.M., Jones F.E., Burow M.E., Hill S.M. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res. 2010, 12:R107.
24. Martín-Renedo J., Mauriz J.L., Jorquera F., Ruiz-Andrés O., González P., González-Gallego J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J. Pineal Res. 2008, 45:532-540.
25. Meyer W.H., Spunt S.L. Soft tissue sarcomas of childhood. Cancer Treat. Rev. 2004, 30:269-280.
26. Mills E., Wu P., Seely D., Guyatt G. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J. Pineal Res. 2005, 39:360-366.
27. Nowfar S., Teplitzky S.R., Melancon K., Kiefer T.L., Cheng Q., Dwived P.D., Bischoff E.D., Moro K., Anderson M.B., Dai J., Lai L., Yuan L., Hill S.M. Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin. Breast Cancer Res Treat 2002, 72:33-43.
28. Ognjanovic S., Linabery A.M., Charbonneau B., Ross J.A. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer 2009, 115:4218-4226.
29. Perdomo J., Cabrera J., Estévez F., Loro J., Reiter R.J., Quintana J. Melatonin induces apoptosis through a caspase-dependent but reactive oxygen species-independent mechanism in human leukemia Molt-3 cells. J. Pineal Res. 2013, 55:195-206.
30. Radogna F., Nuccitelli S., Mengoni F., Ghibelli L. Neuroprotection by melatonin on astrocytoma cell death. Ann. N. Y. Acad. Sci. 2009, 1171:509-513.
31. Rodriguez C., Martín V., Herrera F., García-Santos G., Rodriguez-Blanco J., Casado-Zapico S., Sánchez-Sánchez A.M., Suárez S., Puente-Moncada N., Anítua M.J., Antolín I. Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells. Int. J. Mol. Sci. 2013, 14:6597-6613.
32. Rubin B.P., Nishijo K., Chen H.I., Yi X., Schuetze D.P., Pal R., Prajapati S.I., Abraham J., Arenkiel B.R., Chen Q.R., Davis S., McCleish A.T., Capecchi M.R., Michalek J.E., Zarzabal L.A., Khan J., Yu Z., Parham D.M., Barr F.G., Meltzer P.S., Chen Y., Keller C. Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell 2011, 19:177-191.
33. Sainz R.M., Mayo J.C., Rodriguez C., Tan D.X., Lopez-Burillo S., Reiter R.J. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol. Life Sci. 2003, 60:1407-1426.
34. Salucci S., Burattini S., Curzi D., Buontempo F., Martelli A.M., Zappia G., Falcieri E., Battistelli M. Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. J. Photochem. Photobiol. B 2014, 141:1-9.
35. Salucci S., Burattini S., Battistelli M., Baldassarri V., Curzi D., Valmori A., Falcieri E. Melatonin prevents chemical-induced haemopoietic cell death. Int. J. Mol. Sci. 2014, 15:6625-6640.
36. Sánchez-Hidalgo M., Guerrero J.M., Villegas I., Packham G., de la Lastra C.A. Melatonin: a natural programmed cell death inducer in cancer. Curr. Med. Chem. 2012, 19:3805-3821.
37. Santoro R., Marani M., Blandino G., Muti P., Strano S. Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation. Oncogene 2012, 31:2931-2942.
38. Soundararajan A., Abraham J., Nelon L.D., Prajapati S.I., Zarzabal L.A., Michalek J.E., McHardy S.F., Hawkins D.S., Malempati S., Keller C. 18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models. Pediatr. Blood Cancer 2012, 59:485-492.
39. Wölfler A., Caluba H.C., Abuja P.M., Dohr G., Schauenstein K., Liebmann P.M. Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells. FEBS Lett. 2001, 502:127-131.
40. Wu S.M., Lin W.Y., Shen C.C., Pan H.C., Keh-Bin W., Chen Y.C., Jan Y.J., Lai D.W., Tang S.C., Tien H.R., Chiu C.S., Tsai T.C., Lai Y.L., Sheu M.L. Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via Calpain-mediated C/EBPβ and NFκB cleavage. J. Pineal Res. 2015, 10.1111/jpi.12295.
41. Zanola A., Rossi S., Faggi F., Monti E., Fanzani A. Rhabdomyosarcomas: an overview on the experimental animal models. J. Cell Mol. Med. 2012, 16:1377-1391.